Valuation: Imexpharm Corporation

Market Cap 5,637B 217M 193M 180M 164M 309M 20.89B 313M 2.18B 844M 10.64B 814M 797M 34.16B P/E 2026 *
15.8x
P/E 2027 * 14.6x
Enterprise Value 5,637B 217M 193M 180M 164M 309M 20.89B 313M 2.18B 844M 10.64B 814M 797M 34.16B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.96x
Free-Float
6.42%
Yield 2026 *
2.74%
Yield 2027 * 2.74%
1 day+0.83%
1 week-1.08%
Current month+0.83%
1 month-8.29%
3 months-12.68%
6 months-34.47%
Current year-30.48%
1 week 34,550
Extreme 34550
36,900
1 month 34,550
Extreme 34550
39,750
Current year 32,650
Extreme 32650
57,000
1 year 32,650
Extreme 32650
57,000
3 years 23,681.82
Extreme 23681.818181
57,000
5 years 18,831.17
Extreme 18831.168829
57,000
10 years 13,036.96
Extreme 13036.963036
57,000
Manager TitleAgeSince
Chief Executive Officer 74 01/08/2001
Director of Finance/CFO 52 18/01/2024
Chief Operating Officer 47 -
Director TitleAgeSince
Chairman 74 01/01/1984
Director/Board Member 50 28/04/2018
Director/Board Member - 30/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
9/26/22 A Buy

Chief Executive Officer

140,000 0.2100%
7/20/22 A Sell

Chief Executive Officer

100,000 0.1500%
4/1/22 A Exercice

Chairman

50,000 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+0.83%-1.08%-31.13%+23.99% 216M
-0.54%-2.71%+39.30%+114.07% 1,025B
-0.39%-4.44%+39.03%+66.07% 623B
+0.39%-1.96%+6.36%+74.38% 459B
-0.05%-2.82%+59.56%+39.69% 355B
-0.59%-3.77%+21.95%+39.77% 336B
-1.17%-2.22%+12.61%+25.46% 270B
-0.96%-4.45%-3.69%+9.53% 247B
-0.34%+0.30%+36.44%+51.54% 220B
-0.65%-1.46%+32.70%+96.82% 183B
Average -0.26%-1.81%+21.31%+54.13% 371.84B
Weighted average by Cap. -0.30%-2.11%+30.26%+69.38%

Financials

2026 *2027 *
Net sales 2,659B 102M 90.89M 85M 77.45M 146M 9.85B 148M 1.03B 398M 5.02B 384M 376M 16.12B 2,881B 111M 98.48M 92.09M 83.92M 158M 10.67B 160M 1.11B 431M 5.44B 416M 407M 17.46B
Net income 394B 15.16M 13.47M 12.59M 11.48M 21.61M 1.46B 21.9M 152M 58.98M 743M 56.93M 55.69M 2.39B 428B 16.47M 14.63M 13.68M 12.47M 23.47M 1.59B 23.79M 166M 64.07M 808M 61.84M 60.5M 2.59B
Net Debt - -
Logo Imexpharm Corporation
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Employees
1,438
Date Price Change Volume
01/10/26 ₫36,500.00 +0.83% 920
30/09/26 ₫36,200.00 -1.63% 3,701
29/09/26 ₫36,800.00 0.00% 929
28/09/26 ₫36,800.00 -0.27% 21,728
25/09/26 ₫36,900.00 0.00% 1,851
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
36,500.00VND
Average target price
56,000.00VND
Spread / Average Target
+53.42%

Annual profits - Rate of surprise